MUGHEDDU, CRISTINA
 Distribuzione geografica
Continente #
EU - Europa 15.741
NA - Nord America 1.440
AS - Asia 1.031
SA - Sud America 197
Continente sconosciuto - Info sul continente non disponibili 91
AF - Africa 31
OC - Oceania 1
Totale 18.532
Nazione #
IT - Italia 15.357
US - Stati Uniti d'America 1.391
SG - Singapore 422
CN - Cina 294
BR - Brasile 153
SE - Svezia 121
VN - Vietnam 121
FR - Francia 54
DE - Germania 51
BD - Bangladesh 49
FI - Finlandia 48
GB - Regno Unito 33
HK - Hong Kong 29
CA - Canada 25
IN - India 18
MX - Messico 18
ES - Italia 17
KR - Corea 16
IQ - Iraq 15
NL - Olanda 14
AR - Argentina 13
EC - Ecuador 9
JP - Giappone 9
ZA - Sudafrica 9
IE - Irlanda 8
PK - Pakistan 8
PL - Polonia 8
CO - Colombia 7
ID - Indonesia 7
AT - Austria 6
AE - Emirati Arabi Uniti 5
EG - Egitto 5
UA - Ucraina 5
UZ - Uzbekistan 5
KE - Kenya 4
KZ - Kazakistan 4
MA - Marocco 4
PY - Paraguay 4
RU - Federazione Russa 4
SA - Arabia Saudita 4
TR - Turchia 4
VE - Venezuela 4
HU - Ungheria 3
JO - Giordania 3
NP - Nepal 3
PH - Filippine 3
AZ - Azerbaigian 2
BE - Belgio 2
BO - Bolivia 2
CH - Svizzera 2
CL - Cile 2
IR - Iran 2
JM - Giamaica 2
LV - Lettonia 2
MY - Malesia 2
NG - Nigeria 2
RO - Romania 2
TN - Tunisia 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
AU - Australia 1
BG - Bulgaria 1
BH - Bahrain 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GR - Grecia 1
HN - Honduras 1
IL - Israele 1
KG - Kirghizistan 1
KW - Kuwait 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
TW - Taiwan 1
Totale 18.441
Città #
Cagliari 14.531
Uta 703
Singapore 239
Dallas 168
Ashburn 156
San Jose 126
Fairfield 96
Beijing 65
Boardman 60
Council Bluffs 59
Los Angeles 47
Ho Chi Minh City 45
Houston 41
Helsinki 40
Nyköping 38
Woodbridge 38
Chicago 37
Cambridge 29
Seattle 28
The Dalles 27
Wilmington 27
Hong Kong 26
Lauterbourg 26
Santa Clara 26
Hanoi 25
Hefei 24
Milan 18
New York 16
Ann Arbor 15
Rome 15
Seoul 15
Shanghai 15
São Paulo 15
Boston 13
Redwood City 13
Buffalo 12
Frankfurt am Main 12
Madrid 12
Elk Grove Village 11
London 11
Nuremberg 9
Redondo Beach 9
Salt Lake City 9
Dong Ket 8
Guangzhou 8
San Diego 8
Toronto 8
Brooklyn 7
Charlotte 7
Jacksonville 7
Lappeenranta 7
Orem 7
Warsaw 7
Amsterdam 6
Baghdad 6
Da Nang 6
Hải Dương 6
Mexico City 6
Miami 6
Munich 6
Nanjing 6
Shijiazhuang 6
Tampa 6
Esslingen am Neckar 5
Haiphong 5
Mountain View 5
Naples 5
Ninh Bình 5
Phoenix 5
Rio de Janeiro 5
Shenzhen 5
Belo Horizonte 4
Chandler 4
Chengdu 4
Denver 4
Düsseldorf 4
Johannesburg 4
Latina 4
Montreal 4
Mumbai 4
Nairobi 4
Paris 4
Princeton 4
Senigallia 4
Sterling 4
Tashkent 4
Tianjin 4
Tokyo 4
Turin 4
Vancouver 4
Vienna 4
Almaty 3
Amman 3
Asunción 3
Atlanta 3
Bari 3
Barnet 3
Bexley 3
Brasília 3
Chennai 3
Totale 17.228
Nome #
Psoriasis health care in the time of the coronavirus pandemic: insights from dedicated centers in sardinia (Italy) 2.290
Biologics exposure during pregnancy and breastfeeding in a psoriasis patient 1.554
Successful Guselkumab treatment in a psoriatic patient affected with Cornelia de Lange Syndrome, and prosecution during the COVID-19 pandemic 1.530
Clinical efficacy, speed of improvement and safety of apremilast for the treatment of adult Psoriasis during COVID-19 pandemic 1.495
COVID-19 pulmonary infection in erythrodermic psoriatic patient with oligodendroglioma: safety and compatibility of apremilast with critical intensive care management 1.387
Erythrodermic psoriasis in a dialyzed patient successfully treated with Secukinumab 1.283
Safety of secukinumab treatment in COVID-19 affected psoriatic patients 1.025
Image Gallery: Green moss-like psoriasis 852
Patients' demographic and socioeconomic characteristics influence the therapeutic decision-making process in psoriasis 830
The Challenging Differentiation of Psoriatic Arthritis from Other Arthropathies and Nonspecific Arthralgias in Patients with Psoriasis: Results of a Cross-Sectional Rheumatologic Assessment of a Large Dermatologic Cohort 782
Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy 739
Secukinumab for the treatment of palmoplantar psoriasis: a 2-year, multicenter, real-life observational study 638
Do not forget about myasthenia gravis when performing botulinum toxin injections 605
Real-world outcomes in patients with moderate-to-severe plaque psoriasis treated with guselkumab for up to 1 year 600
Treatment of psoriasis with different classes of biologics reduces the likelihood of peripheral and axial psoriatic arthritis development 562
Multiple Orocutaneous Extraintestinal Manifestations in Ulcerative Colitis Patient: Complete Response to Ustekinumab 466
Dermoscopy of Tinea Incognito 442
Biologic anti-IL17 drugs in erythrodermic psoriasis 252
Long-Term Persistence Rate of Secukinumab in Psoriatic Patients: A Six-Year Multicenter, Real-World Experience, Retrospective Study 244
Rapid Efficacy of riSankizumab in pretibial psoriasis invOLVEment: RESOLVE 230
Real-world analysis of IL-23 inhibitors in patients with moderate-to-severe psoriasis and early musculoskeletal symptoms 182
Tinea Capitis Induced by Barber Shaving: Isolation of Trichophyton tonsurans 131
Efficacy of Calcipotriol/Betamethasone Ointment in Facial Discoid Dermatosis 116
Efficacy and Safety of Intra-Class Switching from Ixekizumab to Secukinumab in Patients with Plaque Psoriasis: A Multicenter Retrospective Study 107
Psoriasis severity, comorbidity burden, and biologic therapy: a multicenter observational study using the Charlson Comorbidity Index 101
The role of guselkumab in psoriatic artrithis and disease progression in patients with confirmed diagnosis of enthesitis 89
Totale 18.532
Categoria #
all - tutte 27.636
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.636


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.137 0 80 86 48 80 151 104 41 82 92 133 240
2022/20232.108 224 237 231 162 214 184 130 124 120 147 171 164
2023/20242.366 122 135 74 112 272 444 223 290 123 163 176 232
2024/20254.668 871 1.230 628 547 325 295 304 38 126 54 159 91
2025/20262.440 129 121 353 169 182 163 470 119 180 264 178 112
2026/202741 39 2 0 0 0 0 0 0 0 0 0 0
Totale 18.532